Patents by Inventor Trevor Morgan
Trevor Morgan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11918443Abstract: A doming tool for manufacturing absorbent tampon includes a plurality of stations made of devices for shaping a tampon pledget tip, and a hollow mandrel engaging with the stations. The stations are supported by at least one mounting plate.Type: GrantFiled: September 16, 2020Date of Patent: March 5, 2024Assignee: Johnson & Johnson GmbHInventors: Nick Brooks, Peter Morgan, James Stembridge, Trevor Whales
-
Publication number: 20240043470Abstract: The compounds of the present invention are represented by the following compounds having Formula I and Formula (I?): where the substituents R1, R2, R2?, R3, R4, R5, R?, R?, X, Y, and Z are as defined herein and where the substituents R1, R2, R3, R4, R5, R?, R?, X, Y, and Z are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.Type: ApplicationFiled: September 25, 2023Publication date: February 8, 2024Inventors: Gang LIN, Carl NATHAN, Laura KIRKMAN, Wenhu ZHAN, Trevor MORGAN, Kenjiro SATO, Ryoma HARA, Masanori KAWASAKI, Toshihiro IMAEDA, Akinori TOITA, Rei OKAMOTO, Takafumi YUKAWA, Kazuyoshi ASO, Tzu-Tshin WONG, John D. GINN, Michael A. FOLEY
-
Patent number: 11834515Abstract: The compounds of the present invention are represented by the following compounds having Formula I and Formula (I?): where the substituents R1, R2, R2?, R3, R4, R5, R?, R?, X, Y, and Z are as defined herein and where the substituents R1, R2, R3, R4, R5, R?, R?, X, Y, and Z are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.Type: GrantFiled: October 11, 2018Date of Patent: December 5, 2023Assignees: CORNELL UNIVERSITY, TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTEInventors: Gang Lin, Carl Nathan, Laura Kirkman, Wenhu Zhan, Trevor Morgan, Kenjiro Sato, Ryoma Hara, Masanori Kawasaki, Toshihiro Imaeda, Akinori Toita, Rei Okamoto, Takafumi Yukawa, Kazuyoshi Aso, Tzu-Tshin Wong, John D. Ginn, Michael A. Foley
-
Patent number: 11732005Abstract: The compounds of the present invention are represented by the following compounds having Formula (I) and Formula (I?): where the substituents R, R1, R3, R4, R, W, X, Y, Z, k, and m are as defined herein and where the substituents R, R1, R2, R3, R4, X, Y, Z, and m are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.Type: GrantFiled: November 8, 2021Date of Patent: August 22, 2023Assignees: CORNELL UNIVERSITY, TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTEInventors: Gang Lin, Carl Nathan, Wenhu Zhan, Trevor Morgan, Ryoma Hara, Toshihiro Imaeda, Rei Okamoto, Kenjiro Sato, Kazuyoshi Aso, Tzu-Tshin Wong, Michael A. Foley
-
Publication number: 20220324907Abstract: The compounds of the present invention are represented by the following compounds having Formula I and Formula (I?): where the substituents R1, R2, R2?, R3, R4, R5, R?, R?, X, Y, and Z are as defined herein and where the substituents R1, R2, R3, R4, R5, R?, R?, X, Y, and Z are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.Type: ApplicationFiled: October 11, 2018Publication date: October 13, 2022Inventors: Gang LIN, Carl NATHAN, Laura KIRKMAN, Wenhu ZHAN, Trevor MORGAN, Kenjiro SATO, Ryoma HARA, Masanori KAWASAKI, Toshihiro IMAEDA, Akinori TOITA, Rei OKAMOTO, Takafumi YUKAWA, Kazuyoshi ASO, Tzu-Tshin WONG, John D. GINN, Michael A. FOLEY
-
Publication number: 20220056073Abstract: The compounds of the present invention are represented by the following compounds having Formula (I) and Formula (I?): where the substituents R, R1, R3, R4, R, W, X, Y, Z, k, and m are as defined herein and where the substituents R, R1, R2, R3, R4, X, Y, Z, and m are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.Type: ApplicationFiled: November 8, 2021Publication date: February 24, 2022Inventors: Gang LIN, Carl NATHAN, Wenhu ZHAN, Trevor MORGAN, Ryoma HARA, Toshihiro IMAEDA, Rei OKAMOTO, Kenjiro SATO, Kazuyoshi ASO, Tzu-Tshin WONG, Michael A. FOLEY
-
Patent number: 11203613Abstract: The compounds of the present invention are represented by the following compounds having Formula (I) and Formula (I?): where the substituents R, R1, R3 R4, R?, W, X, Y, Z, k, and m are as defined herein and where the substituents R, R1, R2, R3, R4, X, Y, Z, and m are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.Type: GrantFiled: October 11, 2018Date of Patent: December 21, 2021Inventors: Gang Lin, Carl Nathan, Wenhu Zhan, Trevor Morgan, Ryoma Hara, Toshihiro Imaeda, Rei Okamoto, Kenjiro Sato, Kazuyoshi Aso, Tzu-Tshin Wong, Michael A. Foley
-
Patent number: 11136310Abstract: A series of 2-imino-6-methyltetrahydropyrimidin-4(1H)-one derivatives, substituted in the 6-position by a phenyl moiety which in turn is meta-substituted by an optionally substituted unsaturated fused bicyclic ring system containing at least one nitrogen atom, being selective inhibitors of plasmepsin V activity, are beneficial as pharmaceutical agents, especially in the treatment of malaria.Type: GrantFiled: November 24, 2016Date of Patent: October 5, 2021Assignee: UCB Biopharma SRLInventors: Rebecca Louise Charlton, Teresa De Haro Garcia, Martin Alexander Lowe, Malcolm Maccoss, Trevor Morgan, Richard David Taylor, Zhaoning Zhu
-
Publication number: 20200317729Abstract: The compounds of the present invention are represented by the following compounds having Formula (I) and Formula (I?): where the substituents R, R1, R3 R4, R?, W, X, Y, Z, k, and m are as defined herein and where the substituents R, R1, R2, R3, R4, X, Y, Z, and m are as defined herein. These compounds are used in the treatment of bacterial infections, parasite infections, fungal infections, cancer, immunologic disorders, autoimmune disorders, neurodegenerative diseases and disorders, inflammatory disorders, or muscular dystrophy or for providing immunosuppression for transplanted organs or tissues.Type: ApplicationFiled: October 11, 2018Publication date: October 8, 2020Inventors: Gang LIN, Carl NATHAN, Wenhu ZHAN, Trevor MORGAN, Ryoma HARA, Toshihiro IMAEDA, Rei OKAMOTO, Kenjiro SATO, Kazuyoshi ASO, Tzu-Tshin WONG, Michael A. FOLEY
-
Publication number: 20200283416Abstract: A series of 2-imino-6-methyltetrahydropyrimidin-4(1H)-one derivatives, substituted in the 6-position by a phenyl moiety which in turn is meta-substituted by an optionally substituted unsaturated fused bicyclic ring system containing at least one nitrogen atom, being selective inhibitors of plasmepsin V activity, are beneficial as pharmaceutical agents, especially in the treatment of malaria.Type: ApplicationFiled: November 24, 2016Publication date: September 10, 2020Inventors: Rebecca Louise Charlton, Teresa De Haro Garcia, Martin Alexander Lowe, Malcolm Maccoss, Trevor Morgan, Richard David Taylor, Zhaoning Zhu
-
Patent number: 8242116Abstract: A series of 6,7-dihydro[1,3]thiazolo[5,4-c]pyridin-4(5H)-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.Type: GrantFiled: June 26, 2007Date of Patent: August 14, 2012Assignee: UCB Pharma S.A.Inventors: Rikki Peter Alexander, Pavandeep Singh Aujla, Karen Viviane Lucile Crépy, Anne Marie Foley, Richard Jeremy Franklin, Alan Findlay Haughan, Helen Tracey Horsley, William Mark Jones, Bénédicte Irma Léonce Frédérique Lallemand, Stephen Robert Mack, Trevor Morgan, Patrick Marie Ghislain Pasau, David Jonathan Phillips, Verity Margaret Sabin, George Martin Buckley, Kerry Jenkins, Benjamin Garfield Perry
-
Patent number: 8093238Abstract: A series of 5,5-dimethyl-5,6-dihydro-1,3-benzothiazol-7(4H)-one and 7,7-dimethyl-5,6,7,8-tetrahydro-4H-[1,3]thiazolo[5,4-c]azepin-4-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted benzofused morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions. Formula (I).Type: GrantFiled: October 10, 2007Date of Patent: January 10, 2012Assignee: UCB Pharma S.A.Inventors: George Martin Buckley, Trevor Morgan, Verity Margaret Sabin
-
Patent number: 7754258Abstract: A porcine collagen film is made from an extrudable collagen gel. The porcine collagen is essentially sow collagen. The ratio of collagen to fat is usually above 10:1, for example in the range 25:1 to 50:1.Type: GrantFiled: February 18, 2004Date of Patent: July 13, 2010Assignee: Devro PLCInventors: Trevor Morgan, Derek Samuel David Norwood, Mark Gray
-
Publication number: 20100137302Abstract: A series of 6,7-dihydro[1,3]thiazolo[5,4-c]pyridin-4(5H)-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions.Type: ApplicationFiled: June 26, 2007Publication date: June 3, 2010Applicant: UCB PHARMA S.A.Inventors: Rikki Peter Alexander, Pavandeep Singh Aujla, Karen Viviane Lucile Crepy, Anne Marie Foley, Richard Jeremy Franklin, Alan Findlay Haughan, Helen Tracey Horsley, William Mark Jones, Benedicte Irma Leonce Frederique Lallemand, Stephen Robert Mack, Trevor Morgan, Patrick Marie Ghislain Pasau, David Jonathan Phillips, Verity Margaret Sabin, George Martin Buckley, Kerry Jenkins, Benjamin Garfield Perry
-
Publication number: 20100069361Abstract: A series of 5,5-dimethyl-5,6-dihydro-1,3-benzothiazol-7(4H)-one and 7,7-dimethyl-5,6,7,8-tetrahydro-4H-[1,3]thiazolo[5,4-c]azepin-4-one derivatives, and analogues thereof, which are substituted in the 2-position by an optionally substituted benzofused morpholin-4-yl moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions. Formula (I).Type: ApplicationFiled: October 10, 2007Publication date: March 18, 2010Applicant: UCB PHARMA S.A.Inventors: George Martin Buckley, Trevor Morgan, Verity Margaret Sabin
-
Publication number: 20060236891Abstract: A porcine collagen film is made from an extrudable collagen gel. The porcine collagen is essentially sow collagen. The ratio of collagen to fat is usually above 10:1, for example in the range 25:1 to 50:1.Type: ApplicationFiled: February 18, 2004Publication date: October 26, 2006Inventors: Trevor Morgan, Derek Norwood, Mark Gray
-
Publication number: 20050031741Abstract: Extruded tubular casing for food-products (such as sausages) is made from an extrudable gel. The gel comprises collagen, fat and a humectant. The collagen content consists essentially of porcine collagen, and the fat content is reduced below that of natural porcine skin or hide. Generally, the ratio of collagen to fat is at least 2.0 to 1 and especially above 10 to 1.Type: ApplicationFiled: August 23, 2002Publication date: February 10, 2005Inventors: Trevor Morgan, Derek Norwood, Gordon Martin
-
Patent number: 4201599Abstract: A method of restoring and/or protecting a cutting surface so that it has an increased effective life comprises applying to the cutting surface a chlorhexidine compound dispersed or dissolved in a carrier therefor. Novel compositions for use for this purpose comprise solutions or suspensions of chlorhexidine compounds in suitable carriers, preferably together with cationic surfactants.Type: GrantFiled: July 6, 1978Date of Patent: May 6, 1980Inventor: Trevor Morgans